Lipids and lipid nanoparticle formulations

US12233161B1 · kind B1 · utility

Assignee

• LONGUIDE BIOPHARMA CORPORATION · CN

Inventors

• Longgui ZHANG · Longbeilingcun, CN
• Yuebao ZHANG · Longbeilingcun, CN
• Chen Liu · Shanghai, CN
• Xiuting Xu · Longbeilingcun, CN
• Yan Wang · Jingwei, CN
• Meigui Liang · Longbeilingcun, CN
• Yuanyuan Xu · 安丰镇, CN
• Wenting Song · Longbeilingcun, CN
• Zehao Liao · Longbeilingcun, CN
• Qinying Zhu · Longbeilingcun, CN
• Yingxin Lu · Longbeilingcun, CN

Key dates

• Filing date: May 20, 2024
• Grant date: Feb 25, 2025
• Expiry date: May 25, 2044

Classification

• Technology area (CPC A): Human Necessities
• CPC primary: A61K47/26
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present disclosure relates generally to lipids, lipid nanoparticle formulations, and methods of using the same for delivering nucleic acids, such as mRNA.